01 2Allergan Inc.
02 1Gowling WLG (Canada) LLP
01 11340316
02 12208704
03 12307632
01 3Gatifloxacin
01 3Ophthalmic Solution
01 12015-12-05
02 12016-01-12
03 12019-08-20
Patent Expiration Date : 2015-12-05
Date Granted : 2005-05-03
Brand Name : ZYMAR
Patent Number : 2208704
Filing Date : 1995-12-05
Strength per Unit : 0.3%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical Ophthalmic
Patent Expiration Date : 2015-12-05
Date Granted : 2005-05-03
Patent Expiration Date : 2019-08-20
Date Granted : 2007-05-22
Brand Name : ZYMAR
Patent Number : 2307632
Filing Date : 1999-08-20
Strength per Unit : 0.3%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical Ophthalmic
Patent Expiration Date : 2019-08-20
Date Granted : 2007-05-22
Patent Expiration Date : 2016-01-12
Date Granted : 1999-01-12
Brand Name : ZYMAR
Patent Number : 1340316
Filing Date : 1987-01-19
Strength per Unit : 0.3%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical Ophthalmic
Patent Expiration Date : 2016-01-12
Date Granted : 1999-01-12
